Quantitative SPECT leads to improved performance in discrimination tasks related to prodromal Alzheimer's disease

Journal of Nuclear Medicine

Volumn 45, Issue 12, 2004, Pages 2026-2031

  El Fakhri, Georges ^a,b   Kijewski, Marie Foley ^a,b   Albert, Marilyn S ^c   Johnson, Keith A ^a,d   Moore, Stephen C ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Attenuation correction; Iterative reconstruction; Prodromal Alzheimer's disease; Quantitative brain SPECT; Resolution recovery; Scatter correction

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; DIAGNOSTIC AGENT;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; HUMAN; IMAGE QUALITY; IMAGE RECONSTRUCTION; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; BRAIN; DEMENTIA; IMAGE PROCESSING; METHODOLOGY; PATHOLOGY; SCINTISCANNING;

AGED; ALZHEIMER DISEASE; BRAIN; DEMENTIA; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; TECHNETIUM TC 99M EXAMETAZIME; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 16644398086     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Stodilka RZ, Kemp BJ, Msaki P, Prato FS, Nicholson RL. The relative contributions of scatter and attenuation corrections toward improved brain SPECT quantification. Phys Med Biol. 1998;43:2991-3008.
2. Rajeevan N, Zubal IG, Ramsby SQ, Zoghbi SS, Seibyl J, Innis RB. Significance of nonuniform attenuation correction in quantitative brain SPECT imaging. J Nucl Med. 1998;39:1719-1726.
3. Iida H, Narita Y, Kado H, et al. Effects of scatter and attenuation correction on quantitative assessment of regional cerebral blood flow with SPECT. J Nucl Med. 1998;39:181-189.
4. 99mTc SPECT brain imaging: a comparison of the use of attenuation maps derived from transmission versus emission data in normal scans. J Nucl Med. 1999;40:456-463.
5. Jagust WJ, Budinger TF, Reed BR. The diagnosis of dementia with single photon emission computed tomography. Arch Neurol. 1987;44:258-262.
6. Johnson KA, Mueller ST, Walsh TM, English R, Holman BL. Cerebral perfusion imaging in Alzheimer's disease: use of SPECT and iofetamine hydrochloride I 123. Arch Neurol. 1987;44:165-169.
7. DeKosky ST, Shih WJ, Schmitt FA, Coupal J, Kirkpatrick C. Assessing utility of single photon emission computed tomography (SPECT) scan in Alzheimer disease: correlation with cognitive severity. Alzheimer Dis Assoc Disord. 1990;4:14-23.
8. Holman BL, Johnson KA, Gerada B, Carvalho PA, Satlin A. The scintigraphic appearance of Alzheimer's disease: a prospective study using technetium-99m-HMPAO SPECT. J Nucl Med. 1992;33:181-185.
9. Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol. 1997;42:85-94.
10. Okamura N, Shinkawa M, Arai H, et al. Prediction of progression in patients with mild cognitive impairment using IMP-SPECT. Nippon Ronen Igakkai Zasshi. 2000;37:974-978.
11. Du A, Schuff N, Amend D, et al. MRI of entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2001;71:441-447.
12. Convit A, de Leon MJ, Tarshish C, et al. Specific hippocampal volume reductions in individuals at risk for Alzheimer's disease. Neurobiol Aging. 1997;18:131-138.
13. De Toledo-Morrell L, Goncharova I, Dickerson B, Wilson RS, Bennett DA. From healthy aging to early Alzheimer's disease: in vivo detection of entorhinal cortex atrophy. Ann NY Acad Sci. 2000;911:240-253.
14. Killiany RJ, Gomez-Isla T, Moss MB, et al. Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease. Ann Neurol. 2000;47:430-439.
15. Kaye JA, Swihart T, Howieson D, et al. Volume loss of the hippocampus and temporal lobe in healthy elderly persons destined to develop dementia. Neurology. 1997;48:1297-1304.
16. Xu Y, Jack CRJ, O'Brien PC, et al. Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD. Neurology. 2000;54:1760-1767.
17. El Fakhri G, Kijewski MF, Johnson KA, et al. MRI-guided SPECT perfusion measures and volumetric MRI in prodromal Alzheimer's disease. Arch Neurol. 2003;60:1066-1072.
18. Hughes WJ, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry. 1982;140:566-572.
19. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939-944.
20. Killiany RJ, Moss MB, Albert MS, Sandor T, Jolesz F. Temporal lobe regions on magnetic resonance imaging identify patients with early Alzheimer's disease. Arch Neurol. 1993;50:949-954.
21. Jaszczak RJ, Floyd CE, Coleman RE. Scatter compensation techniques for SPECT. IEEE Trans Nucl Sci. 1985;32:786-793.
22. Moore SC, Kijewski MF, Muller SP, Rybicki F, Zimmerman RE. Evaluation of scatter compensation methods by their effects on parameter estimation from SPECT projections. Med Phys. 2001;28:278-287.
23. El Fakhri G, Kijewski MF, Moore SC. Absolute activity quantitation from projections using an analytical approach: comparison with iterative methods in Tc-99m and I-123 brain SPECT. IEEE Trans Nucl Sci. 2001;48:768-773.
24. Chang LT. A method for attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sci. 1978;25:638-643.
25. Hudson HM, Larkin RS. Accelerated image reconstruction using ordered subsets of projection data. IEEE Trans Med Imaging. 1994;13:601-609.
26. Pelizzari CA, Chen GTY, Spelbring DR, Weichselbaum RR, Chen CT. Accurate three-dimensional registration of CT, PET, and/or MR images of the brain. J Comput Assist Tomogr. 1989;13:20-26.
27. Holman BL, Zimmerman RE, Johnson KA, et al. Computer-assisted superimposition of magnetic resonance and high-resolution technetium-99m-HMPAO and thallium-201 SPECT images of the brain. J Nucl Med. 1991;32:1478-1484.
28. Rencher AC. Multivariate Statistical Inference and Applications. New York, NY: John Wiley & Sons; 1998:201-210.
29. Press WH, Teukolski SA, Vetterling WT, Flannery BP. Numerical Recipes in Fortran: the Art of Scientific Computing. 2nd ed. Cambridge, U.K.: Cambridge University Press; 1992:617-620.
30. Dorfman DD, Alf E. Maximum likelihood estimation of parameters of signal detection theory and determination of confidence intervals rating method data. J Math Psychol. 1969;6:487-496.
31. Metz CE, Herman BA, Shen JH. Maximum-likelihood estimation of ROC curves from continuously-distributed data. Stat Med. 1998;17:1033-1053.
32. Metz CE, Herman BA, Roe CA. Statistical comparison of two ROC curve estimates obtained from partially-paired datasets. Med Decis Making. 1998;18:110-121.
33. El Fakhri G, Buvat I, Benali H, Todd-Pokropek A, Di Paola R. Relative impact of scatter, collimator response, attenuation, and finite spatial resolution corrections in cardiac SPECT. J Nucl Med. 2000;41:1400-1408.
34. El Fakhri G, Buvat I, Almeida P, Bendriem B, Todd-Pokropek A, Benali H. Should scatter be corrected in both transmission and emission data for accurate quantitation in cardiac SPECT? Eur J Nucl Med. 2000;27:1356-1364.